Jakarta, Dec. 5 -- The Health Ministry stated that they will assess the use and funding coverage by the national health insurance provider, BPJS Kesehatan, of Glucagon-Like Peptide-1 (GLP-1) therapies for obesity treatment, following a recent recommendation from the World Health Organization (WHO).

The ministry's director for control and prevention of non-communicable diseases, Siti Nadia Tarmizi, confirmed here on Friday that currently, they are updating the national clinical guideline for obesity treatment (PNPK), following findings from Free Health Checkup (CKG) that show obesity as a top-five health issue commonly found among adults and the elderly.

"It includes the treatment procedure because all along, treatment is given for those...